New pill aims to tackle diabetes from within
NCT ID NCT05731544
Summary
This study tested a new oral medication called BMF-219 in healthy adults and adults with type 2 diabetes. The main goals were to check the drug's safety and how it affects blood sugar levels over time. Researchers gave different doses to see how well the body handles the drug and if it helps control diabetes.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ark Clinical Research
Long Beach, California, 90815, United States
-
Ark Clinical Research, LLC
Fountain Valley, California, 92708, United States
-
Avantis Clinical Research
Miami, Florida, 33155, United States
-
BC Diabetes
Vancouver, British Columbia, V5Y 3W2, Canada
-
BioPharma Services Inc.
Toronto, M9L 3A2, Canada
-
Carolina Research Center
Shelby, North Carolina, 28150, United States
-
Catalina Research Institute, LLC
Montclair, California, 91763, United States
-
Cedar Crosse Research Center
Chicago, Illinois, 60607, United States
-
Centricity Research LMC
Toronto, Ontario, M4G 3E8, Canada
-
Century Research LLC
Miami, Florida, 33173, United States
-
Clinical Trials of Texas, LLC
San Antonio, Texas, 78229, United States
-
David Kavtaradze MD, Inc
Cordele, Georgia, 31015, United States
-
Diabetes & Glandular Disease Clinic, P.A.
San Antonio, Texas, 78229, United States
-
Diabetes and Endocrinology Associates of Stark County
Canton, Ohio, 44718, United States
-
Entrust Clinical Research
Miami, Florida, 33176, United States
-
G+C Research Group
Hialeah, Florida, 33010, United States
-
Hope Clinical Research
Canoga Park, California, 91303, United States
-
IMA Clinical Research
Austin, Texas, 78745, United States
-
IMA Clinical Research Manhattan
New York, New York, 10036, United States
-
IMA Clinical Research St. Louis
St Louis, Missouri, 63117, United States
-
Manassas Clinical Research
Manassas, Virginia, 20110, United States
-
Medical Care, LLC
Elizabethton, Tennessee, 37643, United States
-
Metro Clinical Trials
San Bernardino, California, 92404, United States
-
Omera Health
Brooklyn, New York, 11220, United States
-
Panax Clinical Research
Miami Lakes, Florida, 33014, United States
-
Privia Medical Group
Savannah, Georgia, 31406, United States
-
Santa Rosa Medical Centers of Nevada
Las Vegas, Nevada, 89119, United States
-
Simcare Medical Research
Sugar Land, Texas, 77478, United States
-
Southwest General Healthcare Center
Fort Myers, Florida, 33907, United States
-
Sunbright Health Research Centers
Homestead, Florida, 33032, United States
-
Synergy Group Medical
Houston, Texas, 77061, United States
-
Synergy Group Medical
Missouri City, Texas, 77459, United States
-
Synergy Groups Medical LLC
Houston, Texas, 77036, United States
-
Velocity Clinical Research
La Mesa, California, 91942, United States
-
Velocity Clinical Research
Dallas, Texas, 75230, United States
-
Velocity Clinical Research
Waco, Texas, 76710, United States
-
Velocity Clinical Research
Jordan, Utah, 84088, United States
-
Wake Forest Health Network, LLC, Medical Plaza
Winston-Salem, North Carolina, 27104, United States
-
Zenos Clinical Research
Dallas, Texas, 75230, United States
Conditions
Explore the condition pages connected to this study.